Filing Details
- Accession Number:
- 0001209191-18-028566
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-05-08 16:18:26
- Reporting Period:
- 2018-05-04
- Accepted Time:
- 2018-05-08 16:18:26
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1293971 | Bluebird Bio Inc. | BLUE | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1350360 | Jason Cole | C/O Bluebird Bio, Inc. 60 Binney Street Cambridge MA 02142 | Chief Legal Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2018-05-04 | 100 | $167.85 | 25,948 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-05-04 | 400 | $169.19 | 25,548 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-05-04 | 900 | $170.48 | 24,648 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-05-04 | 1,890 | $171.25 | 22,758 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-05-04 | 460 | $172.39 | 22,298 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2017.
- The range in prices for the transaction reported on this line was $167.70 to $167.90. The average weighted price was $167.848. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range in prices for the transaction reported on this line was $168.90 to $169.85. The average weighted price was $169.1875. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range in prices for the transaction reported on this line was $169.90 to $170.85. The average weighted price was $170.4833. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range in prices for the transaction reported on this line was $171.00 to $171.55. The average weighted price was $171.2450. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range in prices for the transaction reported on this line was $172.25 to $172.50. The average weighted price was $172.3935. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.